The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.
Adenylyl cyclase type 5 (AC5) is an essential mediator of morphine action
Open accessAbstract
Opioid drugs produce their pharmacological effects by activating inhibitory guanine nucleotide-binding regulatory protein-linked μ, δ, and κ opioid receptors. One major effector for these receptors is adenylyl cyclase, which is inhibited upon receptor activation. However, little is known about which of the ten known forms of adenylyl cyclase are involved in mediating opioid actions. Here we show that all of the major behavioral effects of morphine, including locomotor activation, analgesia, tolerance, reward, and physical dependence and withdrawal symptoms, are attenuated in mice lacking adenylyl cyclase type 5 (AC5), a form of adenylyl cyclase that is highly enriched in striatum. Furthermore, the behavioral effects of selective μ or δ opioid receptor agonists are lost in AC5 −/− mice, whereas the behavioral effects of selective κ opioid receptor agonists are unaffected. These behavioral data are consistent with the observation that the ability of a μ or δ opioid receptor agonist to suppress adenylyl cyclase activity was absent in striatum of AC5 −/− mice. Together, these results establish AC5 as an important component of μ and δ opioid receptor signal transduction mechanisms in vivo and provide further support for the importance of the cAMP pathway as a critical mediator of opioid action.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“genetic knockout of adenylyl cyclase type 5 in mice prevents the reward response to opioids such as morphine [81].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [81]
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 12,859
mouse brain in stereotaxic coordinates
Franklin, K. B. J., & Paxinos, G. (1997) · Cited by 3,258
Matthes, H. W. D., Maldonado, R., Simonin, F., Valverde, O., Slowe, S., Kitchen, I., Befort, K., Dierich, A., Le Meur, M., Dollé, P., et al. (1996) · Nature · doi:10.1038/383819a0 · Cited by 1,722
Molecular and Cellular Basis of Addiction
Nestler, E. J., & Aghajanian, G. K. (1997) · Science · doi:10.1126/science.278.5335.58 · Cited by 1,295
Self-citationKoob, G. F., Sanna, P. P., & Bloom, F. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80557-7 · Cited by 1,026
Neuroanatomy of the pain system and of the pathways that modulate pain
Willis, W. D., & Westlund, K. N. (1997) · Journal of Clinical Neurophysiology · doi:10.1097/00004691-199701000-00002 · Cited by 924
Complexity and Diversity of Mammalian Adenylyl Cyclases
Sunahara, R. K., Dessauer, C. W., & Gilman, A. G. (1996) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.36.040196.002333 · Cited by 874
Mu, delta, and kappa opioid receptor mRNA expression in the rat CNS: An in situ hybridization study
Mansour, A., Fox, C. A., Burke, S., Meng, F., Thompson, R. C., Akil, H., & Watson, S. J. (1994) · The Journal of Comparative Neurology · doi:10.1002/cne.903500307 · Cited by 872
Kelley, A. E. (2004) · Neuron · doi:10.1016/j.neuron.2004.09.016 · Cited by 788
Drug-activation of brain reward pathways
Wise, R. A. (1998) · Drug and Alcohol Dependence · doi:10.1016/s0376-8716(98)00063-5 · Cited by 684
Research works printed but not linked: 2
- T. W. Robbins, B. J. Everitt Learn. Mem 78, 625–636 (2002).
- L. Y. Li, K. J. Chang Mol. Pharmacol 50, 599–602 (1996).
Cited by
Sorted by citations
Multiplex Targeted Sequencing Identifies Recurrently Mutated Genes in Autism Spectrum Disorders
O’Roak, B. J., Vives, L., Fu, W., Egertson, J. D., Stanaway, I. B., Phelps, I. G., Carvill, G., Kumar, A., Lee, C., Ankenman, K., et al. (2012) · Science · doi:10.1126/science.1227764 · Cited by 1,240
Molecular mechanisms of opioid receptor-dependent signaling and behavior
Al-Hasani, R., & Bruchas, M. R. (2011) · Anesthesiology · doi:10.1097/aln.0b013e318238bba6 · Cited by 1,067
Sadana, R., & Dessauer, C. W. (2009) · Neurosignals · doi:10.1159/000166277 · Cited by 361
Dichter, G. S., Damiano, C. A., & Allen, J. A. (2012) · Journal of Neurodevelopmental Disorders · doi:10.1186/1866-1955-4-19 · Cited by 299
Capturing adenylyl cyclases as potential drug targets
Pierre, S. C., Eschenhagen, T., Geißlinger, G., & Scholich, K. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2827 · Cited by 233
Kroslak, T., LaForge, K. S., Gianotti, R. J., Ho, A., Nielsen, D. A., & Kreek, M. J. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04738.x · Cited by 213
Chronic morphine use does not induce peripheral tolerance in a rat model of inflammatory pain
Zöllner, C., Mousa, S. A., Fischer, O., Rittner, H. L., Shaqura, M. A., Brack, A., Shakibaei, M., Binder, W., Urban, F., Stein, C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci25911 · Cited by 130
Molecular Pharmacology of δ-Opioid Receptors
Gendron, L., Cahill, C. M., von Zastrow, M., Schiller, P. W., & Piñeyro, G. (2016) · Pharmacological Reviews · doi:10.1124/pr.114.008979 · Cited by 133
Vitamin D and Its Potential Interplay With Pain Signaling Pathways
Habib, A. M., Nagi, K., Thillaiappan, N. B., Sukumaran, V., & Akhtar, S. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00820 · Cited by 127
HCN2 ion channels: an emerging role as the pacemakers of pain
Emery, E. C., Young, G. T., & McNaughton, P. A. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2012.04.004 · Cited by 118
Ohsawa, I., Nishimaki, K., Murakami, Y., Suzuki, Y., Ishikawa, M., & Ohta, S. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.4956-07.2008 · Cited by 121
Genome-wide association study identifies a potent locus associated with human opioid sensitivity
Nishizawa, D., Fukuda, K., Kasai, S., Hasegawa, J., Aoki, Y., Nishi, A., Saita, N., Koukita, Y., Nagashima, M., Katoh, R., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.164 · Cited by 113
Endogenous opiates and behavior: 2006
Bodnar, R. J. (2007) · Peptides · doi:10.1016/j.peptides.2007.09.002 · Cited by 91
Excessive D1 Dopamine Receptor Activation in the Dorsal Striatum Promotes Autistic-Like Behaviors
Lee, Y., Kim, H., Kim, J., Park, J. Y., Choi, J., Lee, J. E., Lee, E. H., & Han, P. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0770-5 · Cited by 89
Self-citationGarzón, J., Rodríguez-Muñoz, M., & Sánchez‐Blázquez, P. (2012) · Current Drug Abuse Reviews · doi:10.2174/1874473711205030199 · Cited by 89
Isoform Selectivity of Adenylyl Cyclase Inhibitors: Characterization of Known and Novel Compounds
Brand, C. S., Hocker, H. J., Gorfe, A. A., Cavasotto, C. N., & Dessauer, C. W. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.208157 · Cited by 87
Metformin regulates astrocyte reactivity in Parkinson's disease and normal aging
Ryu, Y., Go, J., Park, H., Choi, Y., Seo, Y. J., Choi, J. H., Rhee, M., Lee, T. G., Lee, C., & Kim, K. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108173 · Cited by 74
Self-citationMultiple Actions of Spinophilin Regulate Mu Opioid Receptor Function
Charlton, J. J., Allen, P. B., Psifogeorgou, K., Chakravarty, S., Gomes, I., Neve, R. L., Devi, L. A., Greengard, P., Nestler, E. J., & Zachariou, V. (2008) · Neuron · doi:10.1016/j.neuron.2008.02.006 · Cited by 72
Self-citationZachariou, V., Liu, R., LaPlant, Q., Xiao, G., Renthal, W., Chan, G. C., Storm, D. R., Aghajanian, G., & Nestler, E. J. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2007.11.021 · Cited by 70
Self-citationHo, D., Yan, L., Iwatsubo, K., Vatner, D. E., & Vatner, S. F. (2010) · Heart Failure Reviews · doi:10.1007/s10741-010-9183-5 · Cited by 68
Adenylyl cyclase‐5 activity in the nucleus accumbens regulates anxiety‐related behavior
Kim, K., Lee, K., Baek, I., Lim, C., Krishnan, V., Lee, J., Nestler, E. J., & Han, P. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05592.x · Cited by 66
Self-citationOsorio, D., Zhong, Y., Li, G., Huang, J. Z., & Cai, J. J. (2020) · Patterns · doi:10.1016/j.patter.2020.100139 · Cited by 66
Fan, P., Jiang, Z., Diamond, I., & Yao, L. (2009) · Molecular Pharmacology · doi:10.1124/mol.109.057802 · Cited by 61
Krishnan, V., Graham, A., Mazei-Robison, M. S., Lagace, D. C., Kim, K.-S., Birnbaum, S., Eisch, A. J., Han, P.-L., Storm, D. R., Zachariou, V., et al. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.03.026 · Cited by 56
Self-citationCalmodulin-Stimulated Adenylyl Cyclase Gene Deletion Affects Morphine Responses
Li, S., Lee, M. L., Bruchas, M. R., Chan, G. C., Storm, D. R., & Chavkin, C. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.025783 · Cited by 56
Park, H.-Y., Kang, Y. M., Kang, Y. M., Park, T., Ryu, Y., Hwang, J.-H., Kim, Y.-H., Chung, B.-H., Nam, K., Kim, M. R., et al. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.0864-14.2014 · Cited by 59
Self-citationRodríguez-Muñoz, M., Sánchez‐Blázquez, P., Vicente‐Sánchez, A., Bailón, C., Martín-Aznar, B., & Garzón, J. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0598-x · Cited by 55
Genetic Markers of Comorbid Depression and Alcoholism in Women
Procopio, D. O., Saba, L. M., Walter, H., Lesch, O., Skala, K., Schlaff, G., Vanderlinden, L., Clapp, P., Hoffman, P. L., & Tabakoff, B. (2013) · Alcoholism: Clinical and Experimental Research · doi:10.1111/acer.12060 · Cited by 52
Control of Striatal Signaling by G Protein Regulators
Xie, K., & Martemyanov, K. A. (2011) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2011.00049 · Cited by 52
Sphingosine 1-Phosphate Modulates Spinal Nociceptive Processing
Coste, O., Brenneis, C., Linke, B., Pierre, S. C., Maeurer, C., Becker, W., Schmidt, H., Gao, W., Geißlinger, G., & Scholich, K. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806410200 · Cited by 52
Loss of Adenylyl Cyclase Type-5 in the Dorsal Striatum Produces Autistic-Like Behaviors
Kim, H., Lee, Y., Park, J.-Y., Kim, J.-E., Kim, T.-K., Choi, J., Lee, J.-E., Lee, E.-H., Kim, D., Kim, K.-S., et al. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0256-x · Cited by 50
Self-citationEfendiev, R., Bavencoffe, A., Hu, H., Zhu, M. X., & Dessauer, C. W. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.428144 · Cited by 49
Chidambaran, V., Mavi, J., Esslinger, H. R., Pilipenko, V. V., Martin, L. J., Zhang, K., & Sadhasivam, S. (2014) · The Pharmacogenomics Journal · doi:10.1038/tpj.2014.59 · Cited by 47
Mann, L., Heldman, E., Bersudsky, Y., Vatner, S. F., Ishikawa, Y., Almog, O., Belmaker, R. H., & Agam, G. (2009) · Bipolar Disorders · doi:10.1111/j.1399-5618.2009.00762.x · Cited by 47
Lantero, A., Tramullas, M., Pilar-Cuéllar, F., Valdizán, E. M., Santillán, R., Roques, B. P., & Hurlé, M. A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.4405-13.2014 · Cited by 43
Mice lacking adenylyl cyclase‐5 cope badly with repeated restraint stress
Kim, K., & Han, P. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22119 · Cited by 42
Self-citationConley, J. M., Brand, C. S., Bogard, A. S., Pratt, E. P. S., Xu, R., Hockerman, G. H., Ostrom, R. S., Dessauer, C. W., & Watts, V. J. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.207449 · Cited by 41
Hydrogen Sulfide Attenuates Opioid Dependence by Suppression of Adenylate Cyclase/cAMP Pathway
Yang, H., Wu, Z., Wood, M. E., Whiteman, M., & Bian, J. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.5119 · Cited by 41
Xie, K., Masuho, I., Brand, C. S., DESSAUER, C. W., & Martemyanov, K. A. (2012) · Science Signaling · doi:10.1126/scisignal.2002922 · Cited by 41
Desjardins, S., Belkaï, E., Crété, D., Cordonnier, L., Scherrmann, J., Noble, F., & Cynthia Marie-claire, A. (2008) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.08.027 · Cited by 39
Piñeyro, G., & Nagi, K. (2020) · Cellular Signalling · doi:10.1016/j.cellsig.2020.109906 · Cited by 38
Molecular Changes in Opioid Addiction: The Role of Adenylyl Cyclase and cAMP/PKA System
Chan, P., & Lutfy, K. (2015) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2015.10.005 · Cited by 38
Chen, T. J. H., Blum, K., Waite, R. L., Meshkin, B., Schoolfield, J. D., Downs, B. W., Braverman, E. E., Arcuri, V., Varshavskiy, M., Blum, S. H., et al. (2007) · Advances in Therapy · doi:10.1007/bf02849910 · Cited by 34
Candidate gene polymorphisms predicting individual sensitivity to opioids
Kasai, S., Hayashida, M., Sora, I., & Ikeda, K. (2007) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-007-0205-3 · Cited by 33
de Gortari, P., & Mengod, G. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.009 · Cited by 32
Kim, K.-S., Kim, H., Baek, I.-S., Lee, K.-W., & Han, P.-L. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2143-x · Cited by 31
Self-citationNatural Product Ligands of TRP Channels
Vetter, I., & Lewis, R. J. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-0265-3_3 · Cited by 31
In vivo mapping of a GPCR interactome using knockin mice
Degrandmaison, J., Abdallah, K., Blais, V., Génier, S., Lalumière, M.-P., Bergeron, F., Cahill, C. M., Boulter, J., Lavoie, C. L., Parent, J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1917906117 · Cited by 30
Pierre, S. C., Maeurer, C., Coste, O., Becker, W., Schmidtko, A., Holland, S. M., Wittpoth, C., Geißlinger, G., & Scholich, K. (2008) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m800201-mcp200 · Cited by 29
Mucosal TLR5 activation controls healthspan and longevity
Lim, J. S., Jeon, E. J., Go, H. S., Kim, H., Kim, K. Y., Nguyen, T. Q. T., Lee, D. Y., Kim, K. S., Pietrocola, F., Hong, S. H., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44263-2 · Cited by 32
Self-citationDepolarization induces nociceptor sensitization by CaV1.2-mediated PKA-II activation
Isensee, J., van Cann, M., Despang, P., Araldi, D., Moeller, K., Petersen, J., Schmidtko, A., Matthes, J., Levine, J. D., & Hucho, T. B. (2021) · The Journal of Cell Biology · doi:10.1083/jcb.202002083 · Cited by 27
Src‐dependent phosphorylation of μ‐opioid receptor at Tyr336 modulates opiate withdrawal
Zhang, L., Kibaly, C., Wang, Y., Xu, C., Song, K. Y., McGarrah, P. W., Loh, H. H., Liu, J., & Law, P. (2017) · EMBO Molecular Medicine · doi:10.15252/emmm.201607324 · Cited by 26
Bravo, C., Vatner, D. E., Pachon, R. E., Zhang, J., & Vatner, S. F. (2016) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.116.232538 · Cited by 25
Opioids for Persistent Noncancer Pain
McCleane, G. J., & Smith, H. S. (2007) · Anesthesiology Clinics · doi:10.1016/j.anclin.2007.08.002 · Cited by 25
Wang, S.-C., Lin, J., & Chern, Y. (2009) · Neurosignals · doi:10.1159/000200076 · Cited by 25
Opioid Receptor Signal Transduction Mechanisms
Law, P. (2010) · Humana Press eBooks · doi:10.1007/978-1-60761-993-2_9 · Cited by 23
Kim, H., Kim, T.-K., Kim, J., Park, J. Y., Lee, Y., Kang, M., Kim, K., & Han, P. (2014) · Molecular Brain · doi:10.1186/s13041-014-0077-7 · Cited by 23
Self-citationNuclear Receptor Nr4a1 Regulates Striatal Striosome Development and Dopamine D1Receptor Signaling
Cirnaru, M., Melis, C., Fanutza, T., Naphade, S. B., Tshilenge, K., Muntean, B. S., Martemyanov, K. A., Plotkin, J. L., Ellerby, L., & Ehrlich, M. E. (2019) · eNeuro · doi:10.1523/eneuro.0305-19.2019 · Cited by 23
Olianas, M. C., Dedoni, S., & Onali, P. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.10.005 · Cited by 23
Sutton, L. P., Muntean, B. S., Ostrovskaya, O. I., Zucca, S., Dao, M. T., Orlandi, C., Song, C., Xie, K., & Martemyanov, K. A. (2019) · PLoS Biology · doi:10.1371/journal.pbio.3000477 · Cited by 22
Morales‐Mulia, M., Estrada-Camarena, E. M., Amaya, M. I., Mejía-Mauries, S., Sollozo-Dupont, I., Mengod, G., & de Gortari, P. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.07.036 · Cited by 20
Synthesis of the Mechanisms of Opioid Tolerance: Do We Still Say NO?
Gledhill, L. J., & Babey, A. (2021) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-021-01065-8 · Cited by 19
Drgonová, J., Zimonjic, D. B., Hall, F. S., & Uhl, G. R. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.10.007 · Cited by 18
Opioids for Persistent Noncancer Pain
McCleane, G. J., & Smith, H. S. (2007) · Medical Clinics of North America · doi:10.1016/j.mcna.2006.10.013 · Cited by 18
Milde, M., Rinne, A., Wunder, F., Engelhardt, S. H., & Bünemann, M. (2013) · Biochemical Journal · doi:10.1042/bj20130554 · Cited by 17
Ryu, Y., Park, H., Go, J., Choi, D., Choi, Y., Rhee, M., Lee, C., & Kim, K. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05812-z · Cited by 16
Self-citationGintzler, A. R., & Chakrabarti, S. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.135533 · Cited by 16
Nicotine withdrawal and κ-opioid receptors
McCarthy, M. J., Zhang, H., Neff, N. H., & Hadjiconstantinou, M. (2009) · Psychopharmacology · doi:10.1007/s00213-009-1674-5 · Cited by 16
Opioid-Induced Hyperalgesia and Tolerance Are Driven by HCN Ion Channels
Han, X., Pinto, L. G., Vilar, B., & McNaughton, P. A. (2023) · Journal of Neuroscience · doi:10.1523/jneurosci.1368-23.2023 · Cited by 15
A pharmacogenetics approach to pain management
Yoshida, K., Nishizawa, D., Ide, S., Ichinohe, T., Fukuda, K., & Ikeda, K. (2018) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12003 · Cited by 15
Zhang, W., Cao, H., Li, Y., Fu, X., & Zhang, Y. (2021) · JCI Insight · doi:10.1172/jci.insight.153191 · Cited by 13
Erickson, R. P. (2016) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2015.12.002 · Cited by 13
Adenylyl Cyclase 5: A New Clue in the Search for the "Fountain of Youth"?
Chester, J. A., & Watts, V. J. (2007) · Science s STKE · doi:10.1126/stke.4132007pe64 · Cited by 13
Park, J. Y., Lee, E. H., Kim, J., Paeng, J.-W., Paeng, J.-C., Kim, T.-K., Kim, Y., & Han, P. (2025) · Experimental & Molecular Medicine · doi:10.1038/s12276-025-01429-w · Cited by 12
Self-citationKim, Y., Kang, Y. M., Park, H.-Y., Lee, J.-R., Yu, D., Murata, T., Gondo, Y., Hwang, J. H., Kim, Y., Lee, C., et al. (2016) · Experimental & Molecular Medicine · doi:10.1038/emm.2016.1 · Cited by 12
Self-citationPark, H., Ryu, Y., Go, J., Son, E., Kim, K., & Kim, M. R. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.4.174 · Cited by 12
Self-citationKCTD1 regulation of Adenylyl cyclase type 5 adjusts striatal cAMP signaling
Liao, Y., & Muntean, B. S. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2406686121 · Cited by 11
Eye color: A potential indicator of alcohol dependence risk in European Americans
Sulovari, A., Kranzler, H. R., Farrer, L. A., Gelernter, J. E., & Li, D. (2015) · American Journal of Medical Genetics Part B Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32316 · Cited by 11
Brunori, G., Pelletier, O. B., Stauffer, A. M., & Robishaw, J. D. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1211-21.2021 · Cited by 11
Mice lacking rhes show altered morphine analgesia, tolerance, and dependence
Lee, F. A., Baiamonte, B. A., Spano, D., LaHoste, G. J., Soignier, R. D., & Harrison, L. M. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.12.012 · Cited by 11
Can repeated exposure to morphine change the spinal analgesic effects of lidocaine in rats?
Dabbagh, A., Moghadam, S. F., Rajaei, S., Mansouri, Z., & Manaheji, H. S. (2011) · PubMed Central · Cited by 11
Kim, K.-S., Kim, H., Park, S.-K., & Han, P.-L. (2012) · Brain Research · doi:10.1016/j.brainres.2012.10.016 · Cited by 10
Self-citationBehavioral, neurotransmitter and transcriptomic analyses in male and female Fmr1 KO mice
McCarthy, D. M., Vied, C., Trupiano, M. X., Canekeratne, A. J., Wang, Y., Schatschneider, C. W., & Bhide, P. G. (2024) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2024.1458502 · Cited by 10
Molecular aspects of delta opioid receptors
Gendron, L., Nagi, K., Zeghal, M., Giguère, P. M., & Piñeyro, G. (2019) · Vitamins and hormones · doi:10.1016/bs.vh.2019.06.001 · Cited by 9
The endomorphin-1/2 and dynorphin-B peptides display biased agonism at the mu opioid receptor
LaVigne, J. E., Keresztes, A. I., Chiem, D. N., & Streicher, J. M. (2020) · Pharmacological Reports · doi:10.1007/s43440-020-00061-x · Cited by 9
Shu, H., Hayashida, M., Arita, H., Huang, W., Xiao, L., Chiba, S., Sekiyama, H., & Hanaoka, K. (2008) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2008.07.009 · Cited by 9
NQO1 regulates pharmaco-behavioral effects of d-amphetamine in striatal dopaminergic system in mice
Go, J., Ryu, Y., Park, H., Choi, D., Choi, Y., Hwang, D. Y., Lee, C., & Kim, K. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108039 · Cited by 8
Self-citationConley, J. M., Brust, T. F., Xu, R., Burris, K. D., & Watts, V. J. (2014) · Journal of Visualized Experiments · doi:10.3791/51218 · Cited by 7
Modulation of miR-139-5p on chronic morphine-induced, naloxone-precipitated cAMP overshoot in vitro
Cao, D., Shi, J., Wu, N., & Li, J. (2018) · Metabolic Brain Disease · doi:10.1007/s11011-018-0257-8 · Cited by 7
Liao, Y., & Muntean, B. S. (2025) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2025.110813 · Cited by 5
Park, J. Y., Park, S. Y., Kwon, H., Song, Y., Yun, B., Lee, Y., Cho, Y., Joo, A., & Han, P. (2018) · Experimental Neurobiology · doi:10.5607/en.2018.27.5.387 · Cited by 5
Self-citationZhou, P., Li, Y., Yong, Z., Chen, M., Zhang, Y., Su, R., & Gong, Z. (2020) · Brain Research · doi:10.1016/j.brainres.2020.147083 · Cited by 5
Jr.Devi, G. (2013) · Colloquium Series on Neuropeptides · doi:10.4199/c00082ed1v01y201304npe004 · Cited by 5
Aoki, Y., Nishizawa, D., Yoshida, K., Hasegawa, J., Kasai, S., Takahashi, K., Koukita, Y., Ichinohe, T., Hayashida, M., Fukuda, K., et al. (2018) · Neuropsychopharmacology Reports · doi:10.1002/npr2.12012 · Cited by 5
Mansour, A. M., Nagi, K., Dallaire, P., Lukasheva, V., Gouill, C. L., Bouvier, M., & Piñeyro, G. (2021) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.1c00019 · Cited by 5
Kim, H., Lee, Y., Kim, J., & Han, P. (2016) · Experimental Neurobiology · doi:10.5607/en.2016.25.2.79 · Cited by 5
Self-citationLabel-free fluorescent real-time monitoring of adenylyl cyclase
Rhee, H., Kim, K., Han, P., & Hong, J.-I. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.12.018 · Cited by 4
Self-citationNanotechnology-Enhanced Naloxone and Alternative Treatments for Opioid Addiction
Heyns, I. M., Faunce, A. F., Mumba, M. N., Kumar, M. N. V. R., & Arora, M. (2024) · ACS Pharmacology & Translational Science · doi:10.1021/acsptsci.4c00158 · Cited by 3
Ding, Z., Zhang, C., Yang, H., Chen, J., Sun, Z., & Zhen, X. (2024) · PLoS Biology · doi:10.1371/journal.pbio.3002716 · Cited by 3
Pan, W., & Li, Y. (2023) · Journal of Herbal Medicine · doi:10.1016/j.hermed.2023.100784 · Cited by 1
Metadata
- Authors
- Kim, K.-S., Lee, K.-W., Lee, K.-W., Im, J.-Y., Yoo, J. Y., Kim, S.-W., Lee, J.-K., Nestler, E. J., & Han, P.-L.
- Affiliations
- Ewha Womans University (KR)
- Inha University (KR)
- The University of Texas Southwestern Medical Center (US)
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2006-02-28
- Volume
- 103
- Issue
- 10
- Pages
- 3908-3913
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2139496188
- Cited by
- 123
- References
- 51
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 6 · 2023: 2 · 2022: 2 · 2021: 6 · 2020: 10 · 2019: 3 · 2018: 4 · 2017: 3 · 2016: 8 · 2015: 4 · 2014: 5 · 2013: 7 · 2012: 13
- FWCI
- 4.30
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- adenylyl cyclase type 5, morphine, opioid receptors, mu-opioid receptor, delta opioid receptor, kappa opioid receptor, striatum, cAMP signaling, opioid tolerance, opioid reward, opioid use disorder, opioid withdrawal, analgesia, locomotor activation
- MeSH terms
- Adenylyl Cyclases, Animals, Behavior, Animal, Conditioning, Psychological, Corpus Striatum, Isoenzymes, Mice, Inbred C57BL, Morphine, Motor Activity, Pain Measurement, Receptors, Opioid, Substance Withdrawal Syndrome, Signal Transduction, Receptors, Opioid, mu, Receptors, Opioid, delta, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review